ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 480

Local Cryotherapy Down-Regulates Local and Systemic IL-6/IL-17 Pathway with No Effect on TNF-α in Adjuvant-Induced Arthritis

Xavier Guillot1,2, Hélène Martin1, Katy Maguin-Gaté1, Stéphanie Py3, Céline Demougeot1, Daniel Wendling4 and Nicolas Tordi5, 1EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche-Comté, Besançon, France, 2EA 4267 FDE, FHU INCREASE, Bourgogne Franche-Comté University, Besançon, France, 3INSERM-CIC 1431, Besançon University Hospital, Besançon, France, Besançon, France, 4Rheumatology, Besançon university hospital, Besançon, France, 5EA 4267 FDE, FHU INCREASE,, Bourgogne Franche-Comté University, Besançon, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: adjuvant arthritis, arthritis management, cytokines, inflammation and physical therapy

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cryotherapy is widely and empirically used in an adjuvant and symptomatic setting in inflammatory rheumatic diseases, with a low level of evidence [1]. The aim of this work was to evaluate local and systemic anti-inflammatory effects of local cryotherapy (LC) in adjuvant-induced arthritis (AIA), comparing 2 techniques (ice and cold gas spray). We considered clinical (arthritis score and ankle diameter) and biological effects on IL-6, IL-17A, IL-1β, TNF-α local and systemic levels.

Methods: Arthritis was induced by a single Mycobacterium butyricum injection in male Lewis rat tails (day 0). At the onset of arthritis (day 11), rats were treated either by 30 minute-ice applications on hind paws (in cages lined with ice pops – n=10) or by 2 minute-cold gas pulverizations on both hind paws (n=9) twice a day for 14 consecutive days. Ten non-treated AIA rats were used as controls. At day 24 (the day after the last cold application), hind paws were grinded in order to measure cytokine gene expression levels by Q-RT-PCR. Plasmatic levels of the same cytokines were also measured in plasma by cytometry (Multiplex Magpix® ebioscience). IL-6 plasma levels were measured by ELISA (rat IL6 platinum ELISA, BMS625®, ebioscience).

Results: Ice application significantly reduced the mean arthritis score and ankle diameter from day 6 to day 14 (p<0.001) and globally throughout the 14 day treatment period (2-way ANOVA: p<0.001) compared to non-treated AIA controls. Cold gas first aggravated arthritis at days 11-12 (p<0.01) then improved clinical inflammation at days 21-24 (p<0.001). Skin temperature after LC didn’t differ between treatment groups. Both techniques significantly reduced IL-6, IL-1β, IL-17A gene expression levels in hind paws at day 24 compared to non-treated AIA (by 60%, 87% and 50% respectively, p<0.001,p<0.001 and p<0.05). Cytokine gene expression levels correlated positively with hind paw arthritis score and ankle diameter. Conversely, LC had no effect on TNF-α gene expression in hind paws. LC also significantly reduced IL-17A plasmatic protein levels at day 24 (Ice : 47+/-3pg/ml versus 132+/-15pg/ml;n=9;p<00001 – cold gas : 89+/-12pg/ml versus 132+/-15pg/ml;p<0.02) and IL-17A plasmatic levels correlated positively with arthritis score, ankle diameter and negatively with weight gain. Ice also reduced IL-6 plasmatic levels (118+/-20pg/ml versus 197+/-60pg/ml;p<0.05) and IL-6 plasmatic levels correlated positively with ankle diameter. By contrast, LC had no effect on TNF-α nor IL-1β plasmatic levels.

Conclusion: These results demonstrate in vivo previously unknown therapeutic and anti-inflammatory effects of 14 day-LC in AIA. We observed both local (at the gene level in treated hind paws) and systemic (at the protein level in plasma) down-regulation of key cytokine pathways critically involved in the pathogenesis and severity of inflammatory rheumatic diseases. LC local and systemic anti-inflammatory effects were mainly IL-6 / IL-17A-driven and TNF-α-independent in this model. [1] Guillot X, et al. Cryotherapy in inflammatory rheumatic diseases: a systematic review. Expert Rev Clin Immunol. 2014;10(2):281-94.


Disclosure: X. Guillot, None; H. Martin, None; K. Maguin-Gaté, None; S. Py, None; C. Demougeot, None; D. Wendling, None; N. Tordi, None.

To cite this abstract in AMA style:

Guillot X, Martin H, Maguin-Gaté K, Py S, Demougeot C, Wendling D, Tordi N. Local Cryotherapy Down-Regulates Local and Systemic IL-6/IL-17 Pathway with No Effect on TNF-α in Adjuvant-Induced Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/local-cryotherapy-down-regulates-local-and-systemic-il-6il-17-pathway-with-no-effect-on-tnf-%ce%b1-in-adjuvant-induced-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/local-cryotherapy-down-regulates-local-and-systemic-il-6il-17-pathway-with-no-effect-on-tnf-%ce%b1-in-adjuvant-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology